ArticleBiomarker research2023
The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses.
Yungchang Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it